Market Tracker

12/06 4:58am ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.308
Delayed Data
As of Dec 05
 0.00 / 0.00%
Today’s Change
0.29
Today|||52-Week Range
1.31
-73.68%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.31
Today’s openn.a.
Day’s range-- - --
Volume6,019
Average volume (3 months)1,057,698
Market cap$73.9M
Dividend yield--
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
LIFEaTyr Pharma Inc+0.20+6.56%
AGLEAeglea Bio Therapeut...+0.04+0.70%
SBPHSpring Bank Pharmace...0.000.00%
ALIMAlimera Sciences Inc+0.04+3.74%
Data as of 12/05/2016

Financials

Next reporting dateDecember 12, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts